US Bancorp DE Has $3.77 Million Position in The Cooper Companies, Inc. (NASDAQ:COO)

US Bancorp DE lessened its position in The Cooper Companies, Inc. (NASDAQ:COO) by 3.3% in the fourth quarter, Holdings Channel.com reports. The firm owned 41,007 shares of the medical device company’s stock after selling 1,416 shares during the quarter. US Bancorp DE’s holdings in Cooper Companies were worth $3,770,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Wealth Enhancement Advisory Services LLC increased its stake in shares of Cooper Companies by 33.3% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 9,061 shares of the medical device company’s stock valued at $1,000,000 after buying an additional 2,264 shares during the period. Stephens Inc. AR increased its stake in shares of Cooper Companies by 16.9% in the third quarter. Stephens Inc. AR now owns 3,570 shares of the medical device company’s stock valued at $394,000 after buying an additional 516 shares during the period. Janney Montgomery Scott LLC increased its stake in shares of Cooper Companies by 0.5% in the third quarter. Janney Montgomery Scott LLC now owns 100,222 shares of the medical device company’s stock valued at $11,058,000 after buying an additional 485 shares during the period. Forum Financial Management LP acquired a new stake in shares of Cooper Companies in the third quarter valued at about $204,000. Finally, Asset Management One Co. Ltd. increased its stake in shares of Cooper Companies by 1.2% in the third quarter. Asset Management One Co. Ltd. now owns 80,149 shares of the medical device company’s stock valued at $8,844,000 after buying an additional 964 shares during the period. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently weighed in on COO. Morgan Stanley decreased their price target on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. Citigroup decreased their price target on Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research note on Friday, December 6th. StockNews.com cut Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Finally, Wells Fargo & Company upped their target price on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research report on Friday, December 6th. Three analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $117.22.

Cooper Companies Stock Up 0.7 %

Shares of NASDAQ:COO opened at $91.33 on Thursday. The business’s 50 day simple moving average is $92.56 and its two-hundred day simple moving average is $99.51. The firm has a market cap of $18.23 billion, a P/E ratio of 46.84, a PEG ratio of 2.25 and a beta of 1.02. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The Cooper Companies, Inc. has a 52-week low of $84.76 and a 52-week high of $112.38.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.00 by $0.04. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company’s quarterly revenue was up 9.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.87 earnings per share. As a group, research analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.